2023
DOI: 10.1016/j.retram.2022.103367
|View full text |Cite
|
Sign up to set email alerts
|

Multiomics and artificial intelligence enabled peripheral blood-based prediction of amnestic mild cognitive impairment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…Ribosomes stall during the co-translational transport of APP.C99 in the ER membrane and Are rescued by RQC; however, insufficient RQC adds CAT-tail-like C-terminal extensions onto APP.C99, which are prone to aggregation and cause lysosomal dysfunction [139]. Interestingly, previously, we demonstrated that miR-NAs targeting GCN1 are selectively downregulated in the peripheral blood of patients with amnestic mild cognitive impairment, a pre-disease state of Alzheimer's disease, indicating that GCN1-mediated quality control may be enhanced in amnestic mild cognitive impairment [140]. In addition, whole-blood transcriptome and plasma metabolome analyses suggested an AAS response in undetermined cells in the peripheral blood.…”
Section: Potential Role Of Gcn1 In Neurodegenerative Diseasesmentioning
confidence: 83%
“…Ribosomes stall during the co-translational transport of APP.C99 in the ER membrane and Are rescued by RQC; however, insufficient RQC adds CAT-tail-like C-terminal extensions onto APP.C99, which are prone to aggregation and cause lysosomal dysfunction [139]. Interestingly, previously, we demonstrated that miR-NAs targeting GCN1 are selectively downregulated in the peripheral blood of patients with amnestic mild cognitive impairment, a pre-disease state of Alzheimer's disease, indicating that GCN1-mediated quality control may be enhanced in amnestic mild cognitive impairment [140]. In addition, whole-blood transcriptome and plasma metabolome analyses suggested an AAS response in undetermined cells in the peripheral blood.…”
Section: Potential Role Of Gcn1 In Neurodegenerative Diseasesmentioning
confidence: 83%
“…In this respect, we have recently hypothesized that CD8+ T emra cells migrating into peripheral tissues, including the CNS, may fine‐tune CNS homeostasis through the secretion of IFN‐ɣ, TGF‐β, and IL‐10, and the interaction between HLA class I molecules and inhibitory NK receptors 54 . Interestingly, a recent multiomics study with peripheral blood samples from amnestic mild cognitive impairment (aMCI) patients has revealed that T cells with immunosuppressor function (without ascertaining whether CD4+ or CD8+, or both) represent a biomarker associated with aMCI 55 …”
Section: Discussionmentioning
confidence: 99%
“…54 Interestingly, a recent multiomics study with peripheral blood samples from amnestic mild cognitive impairment (aMCI) patients has revealed that T cells with immunosuppressor function (without ascertaining whether CD4+ or CD8+, or both) represent a biomarker associated with aMCI. 55…”
Section: Relevance Of the Hla-a23 Or Hla-a24 Serotypes In The Context...mentioning
confidence: 99%
“…Ribosomes stall during the co-translational transport of APP.C99 in the ER membrane and Are rescued by RQC; however, insufficient RQC adds CAT-tail-like C-terminal extensions onto APP.C99, which are prone to aggregation and cause lysosomal dysfunction [ 139 ]. Interestingly, previously, we demonstrated that miRNAs targeting GCN1 are selectively downregulated in the peripheral blood of patients with amnestic mild cognitive impairment, a pre-disease state of Alzheimer’s disease, indicating that GCN1-mediated quality control may be enhanced in amnestic mild cognitive impairment [ 140 ]. In addition, whole-blood transcriptome and plasma metabolome analyses suggested an AAS response in undetermined cells in the peripheral blood.…”
Section: Potential Role Of Gcn1 In Aging and Diseasementioning
confidence: 99%